XPRO India LtdQ1 FY26
XPRO India Ltd
Q1 FY26 Earnings Call Analysis
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →Ras Al Khaimah (RAK) plant expected to start trial production by August-September 2026, with commercial production by Q3 FY27, targeting over 50% capacity utilization by FY27-FY28.
- →Two Indian lines expected to be in full production in FY27, aiming for at least 50% utilization on the new Barjora line with volume growth underway.
- →Efforts to move towards higher value-added and ultrathin dielectric films (2-5 microns) to diversify product mix and increase revenue contribution.
- →Volume in coex division declined from ~33,014 MT to ~31,335 MT in FY26; growth expected as new capacity utilization increases.
- →Management focuses on volume growth, margin enhancement, and onboarding new customers for new capacities.
- →Price increases expected due to polymer/raw material cost inflation, but sustainability depends on market stability.
Margin guidance
Category 3- →Ras Al Khaimah (RAK) plant expected to start trial production by August-September 2026, with commercial production likely by Q3 FY27.
- →Full capacity utilization anticipated for two Indian lines in FY27 and FY28; UAE line expected to reach over 50% capacity utilization in FY27-28.
- →EBITDA margins expected to improve with new capacity and higher value-added specialty films, although no specific margin forecast disclosed.
- →Volume in coex division declined from 33,014 tons to 31,335 tons in FY26 due to production slowdown; expected to pick up in FY27.
- →Pricing environment volatile due to raw material (polymer) cost increases and forex fluctuations; price increases expected to stabilize at decent levels, benefiting margins.
- →Continued focus on higher value specialty films including ultrathin (2-5 micron) films, aiming for gradual mix shift in product portfolio over next 2-3 years.
- →Management optimistic about sustained earnings growth driven by capacity additions, premium product mix, and expanding market share.
Sign up free to read the full earnings analysis
Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for XPRO India Ltd and 1,400+ other companies.
Fundraise plans
- →No outstanding long-term borrowings for existing operations.
- →The company has availed supplier credit in the nature of ECB (External Commercial Borrowing) for financing the new line at Barjora.
- →Repayments of the ECB have already commenced, with 3 instalments repaid so far.
- →Fresh equity of USD 9 million was raised for the UAE subsidiary from a significant UAE participant, fully received and used for growth.
- →INR 74.63 crores raised via preferential infusion and QIP are held in banks pending utilization for stated purposes.
- →No mention of any planned new fundraising through debt or equity in the near future.
- →Board approved dividend INR 2 per share, indicating confidence in financial position without immediate need for new fundraising.
Order book
- →The company has customers who want far more material than current limited capacity allows.
- →Existing customers require more volumes than presently supplied, indicating strong order demand.
- →Sales from the second line at Barjora have started with some products under approval.
- →No specific quantitative order book or pending orders value was disclosed during the call.
- →Demand is progressively ramping up, but capacity constraints currently limit the full fulfillment.
- →New customer onboarding and applications are underway for the new capacity.
- →Management focuses on volume growth and margin enhancement amidst dynamic pricing.
- →No indication of order backlog delays; expansion lines are expected to meet growing demand in FY '27 and FY '28.
Capex plans
Yes- →The biggest single capex chunk in FY 2026-27 is the Ras Al Khaimah (RAK) plant, expected to be capitalized around mid-year.
- →Additional capex may be done for value-added bits at the Bajora plant.
- →Coex operations in Ranjangaon and Greater Noida will see modest, routine capex but no new lines to be capitalized in FY 2026-27.
- →The Barjora line has already been capitalized (approx. INR 240 crores).
- →The Ras Al Khaimah line is still work in progress and not yet capitalized.
- →Fresh equity of USD 9 million was infused into the UAE subsidiary for growth.
- →Supplier credit in the form of ECB has been used to finance the new line at Barjora, with repayments underway.
- →The company is exploring Production Linked Incentive (PLI) opportunities for future lines, not yet applied for.
How does XPRO India Ltd rank vs peers in Industrial Products?
Pro feature1XPRO India Ltd
Rev 3Mar 3
See full Industrial Products sector rankings
Unlock with ProWant more stocks like XPRO India Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio